Roivant launches LISRAYA commercially at $35,000 per 30-count
Roivant Sciences launches LISRAYA commercially at $35,000 per 30-count, alongside a presentation on FDA approval.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.